Serum response factor: Toggling between disparate programs of gene expression

Journal of Molecular and Cellular Cardiology

Volumn 35, Issue 6, 2003, Pages 577-593

  Miano, Joseph M ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Bioinformatics; Calponin; Evolution; Genome; Integrin; Myocardin; Myosin; Promoter; SM22; Smooth muscle; Transgenic

Indexed keywords

ALPHA ACTIN; CIS ACTING ELEMENT; EARLY GROWTH RESPONSE FACTOR 1; PROTEIN C FOS; RNA POLYMERASE II; SERUM RESPONSE FACTOR;

AMINO ACID SUBSTITUTION; CLINICAL RESEARCH; DNA BINDING; DNA FLANKING REGION; DNA FOOTPRINTING; DNA SPLICING; GENE ACTIVATION; GENE EXPRESSION; HELA CELL; HUMAN; MOLECULAR CLONING; MUTAGENESIS; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; REVIEW; TRANSCRIPTION INITIATION; ZINC FINGER MOTIF;

MAMMALIA; MUS MUSCULUS;

EID: 0037870478     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2828(03)00110-X     Document Type: Review

References (185)

1. Ko M.S.H. A stochastic model for gene induction. J Theor Biol. 153:1991;181-194.
2. Elowitz M.B., Levine A.J., Siggia E.D., Swain P.S. Stochastic gene expression in a single cell. Science. 297:2002;1183-1186.
3. Olson E.N. MyoD family: a paradigm for development. Gene Dev. 4:1990;1454-1461.
4. Weintraub H., Davis R., Tapscott S.J., Thayer M.J., Krause M., Benezra R., et al. The myoD gene family: nodal point during specification of the muscle cell lineage. Science. 251:1991;761-766.
5. Olson E.N., Klein W.H. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Gene Dev. 8:1994;1-8.
6. Firulli A.B., Thattaliyath B.D. Transcription factors in cardiogenesis: the combinations that unlock the mysteries of the heart. Int Rev Cytol. 214:2002;1-62.
7. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 75:1995;487-517.
8. Miano J.M. Mammalian smooth muscle differentiation: origins, markers and transcriptional control. Res Probl Cell Diff. 38:2002;39-59.
9. Johansen F.E., Prywes R. Serum response factor: transcriptional regulation of genes induced by growth factors and differentiation. Biochim Biophys Acta. 1242:1995;1-10.
10. Campbell G.R., Campbell J.H. Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis. Exp Mol Pathol. 42:1985;139-162.
11. Solway J., Forsythe S.M., Halayko A.J., Vieira J.E., Hershenson M.B., Camoretti-Mercado B. Transcriptional regulation of smooth muscle contractile apparatus expression. Am J Respir Crit Care M. 158:1998;S100-108.
12. Hungerford J.E., Little C.D. Developmental biology of the vascular smooth muscle cell: building a multilayered vessel wall. J Vasc Res. 36:1999;2-27.
13. Sobue K., Hayashi K., Nishida W. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem. 190:1999;105-118.
14. Halayko A.J., Solway J. Molecular mechanisms of phenotypic plasticity in smooth muscle cells. J Appl Physiol. 90:2001;358-368.
15. Parmacek M.S. Transcriptional programs regulating vascular smooth muscle cell development and differentiation. Curr Top Dev Biol. 51:2001;69-89.
16. Moiseeva E.P. Adhesion receptors of vascular smooth muscle cells and their function. Cardiovasc Res. 52:2001;372-386.
17. Greenberg M.E., Ziff E.B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature. 311:1984;433-438.
18. Treisman R. Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5' element and c-fos 3' sequences. Cell. 42:1985;889-902.
19. Deschamps J., Meijink F., Verma I.M. Identification of a transcriptional enhancer element upstream from the proto-oncogene fos. Science. 230:1985;1174-1177.
20. Treisman R. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell. 46:1986;567-574.
21. Prywes R., Roeder R.G. Inducible binding of a factor to the c-fos enhancer. Cell. 47:1986;777-784.
22. Gilman M.Z., Wilson R.N., Weinberg R.A. Multiple protein-binding sites in the 5'-flanking region regulate c-fos expression. Mol Cell Biol. 6:1986;4305-4316.
23. Minty A., Kedes L. Upstream regions of the human cardiac actin gene that modulate its transcription in muscle cells: presence of an evolutionarily conserved repeated motif. Mol Cell Biol. 6:1986;2125-2136.
24. Miwa T., Kedes L. Duplicated CArG box domains have positive and mutually dependent regulatory roles in expression of the human α-cardiac actin gene. Mol Cell Biol. 7:1987;2803-2813.
25. Phan-Dinh-Tuy F., Tuil D., Schweighoffer F., Pinset C., Kahn A., Minty A. The "CC.Ar.GG" box: a protein-binding site common to transcription-regulatory regions of the cardiac actin, c-fos, and interleukin-2 receptor genes. Eur J Biochem. 173:1988;507-515.
26. Miano J.M., Tota R.R., Vlasic N., Danishefsky K.J., Stemerman M.B. Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal. Am J Pathol. 137:1990;761-765.
27. Majesky M.W., Reidy M.A., Bowen-Pope D.F., Hart C.E., Wilcox J.N., Schwartz S.M. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol. 111:1990;2149-2158.
28. Taubman M.B., Rollins B.J., Poon M., Marmur J., Green R.S., Berk B.C., et al. JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ Res. 70:1992;314-325.
29. Miano J.M., Vlasic N., Tota R.R., Stemerman M.B. Smooth muscle cell immediate early gene and growth factor activation follows vascular injury: a putative in vivo mechanism for autocrine growth. Arterioscler Thromb. 13:1993;211-219.
30. Miano J.M., Vlasic N., Tota R.R., Stemerman M.B. Localization of Fos and Jun proteins in rat aortic smooth muscle cells after vascular injury. Am J Pathol. 142:1993;715-724.
31. Pritchard K.A. Jr, O'Banion M.K., Miano J.M., Vlasic N., Bhatia U.G., Young D.A., et al. Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo. J Biol Chem. 269:1994;8504-8509.
32. Santiago F.S., Lowe H.C., Day F.L., Chesterman C.N., Khachigian L.M. Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2. Am J Pathol. 154:1999;937-944.
33. Verger A., Duterque-Coquillaud M. When Ets transcription factors meet their partners. BioEssays. 24:2002;362-370.
34. Hultgårdh-Nilsson A., Cercek B., Wang J.W., Naito S., Lovdahl C., Sharifi B., et al. Regulated expression of the Ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitro. Circ Res. 78:1996;589-595.
35. Treisman R. Identification and purification of a polypeptide that binds to the c-fos promoter serum response element. EMBO J. 6:1987;2711-2717.
36. Prywes R., Roeder R.G. Purification of the c-fos enhancer-binding protein. Mol Cell Biol. 7:1987;3482-3489.
37. Boxer L.M., Prywes R., Roeder R.G., Kedes L. The sarcomeric actin CArG-binding factor is indistinguishable from the c-fos serum response factor. Mol Cell Biol. 9:1989;515-522.
38. Taylor M., Treisman R., Garrett N., Mohun T. Muscle-specific (CArG) and serum-responsive (SRE) promoter elements are functionally interchangeable in Xenopus embryos and mouse fibroblasts. Development. 106:1989;67-78.
39. Norman C., Runswick M., Pollock R., Treisman R. Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell. 55:1988;989-1003.
40. Belaguli N.S., Schildmeyer L.A., Schwartz R.J. Organization and myogenic restricted expression of the murine serum response factor gene: a role for autoregulation. J Biol Chem. 272:1997;18222-18231.
41. Spencer J.A., Misra R.P. Expression of the serum response factor gene is regulated by serum response factor binding sites. J Biol Chem. 271:1996;16535-16543.
42. Shore P., Sharrocks A.D. The MADS-box family of transcription factors. Eur J Biochem. 229:1995;1-13.
43. Black B.L., Olson E.N. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol. 14:1998;167-196.
44. Reecy J.M., Belaguli N.S., Schwartz R.J. Serum response factor-NK homeodomain factor interactions, role in cardiac development. Harvey R.P., Rosenthal N. Heart development. 1999;273-290 Academic Press, New York.
45. Misra R.P., Rivera V.M., Wang J.M., Fan P.D., Greenberg M.E. The serum response factor is extensively modified by phosphorylation following its synthesis in serum-stimulated fibroblasts. Mol Cell Biol. 11:1991;4545-4554.
46. Croissant J.D., Kim J.H., Eichele G., Goering L., Lough J., Prywes R., et al. Avian serum response factor expression restricted primarily to muscle cell lineages is required for α-actin gene transcription. Dev Biol. 177:1996;250-264.
47. Mohun T., Garrett N., Treisman R. Xenopus cytoskeletal actin and human c-fos gene promoters share a conserved protein-binding site. EMBO J. 6:1987;667-673.
48. Leung S., Miyamoto N.G. Point mutational analysis of the human c-fos serum responsible factor binding site. Nucl Acid Res. 14:1989;1177-1195.
49. Pellegrini L., Tan S., Richmond T.J. Structure of serum response factor core bound to DNA. Nature. 376:1995;490-498.
50. Miano J.M., Olson E.N. Expression of the smooth muscle cell calponin gene marks the early cardiac and smooth muscle cell lineages during mouse embryogenesis. J Biol Chem. 271:1996;7095-7103.
51. 6GG elements with c-fos serum response elements results in increased basal expression but relaxed SM cell specificity and reduced angiotensin II inducibility. J Biol Chem. 273:1998;8398-8406.
52. Miano J.M., Carlson M.J., Spencer J.A., Misra R.P. Serum response factor-dependent regulation of the smooth muscle calponin gene. J Biol Chem. 275:2000;9814-9822.
53. SRF is expressed and required during myogenic differentiation of both mouse C2 and rat L6 muscle cell lines. J Cell Biol. 118:1992;1489-1500.
54. Soulez M., Gauthier-Rouvière C., Chafey P., Hentzen D., Vandromme M., Lautredou N., et al. Growth and differentiation of C2 myogenic cells are dependent on serum response factor. Mol Cell Biol. 16:1996;6065-6074.
55. Arsenian S., Weinhold B., Oelgeschlager M., Ruther U., Nordheim A. Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J. 17:1998;6289-6299.
56. -/- ES cells display non-cell-autonomous impairment in mesodermal differentiation. EMBO J. 19:2000;5835-5844.
57. Landerholm T.E., Dong X- R., Lu J., Belaguli N.S., Schwartz R.J., Majesky M.W. A role for serum response factor in coronary smooth muscle differentiation from proepicardial cells. Development. 126:1999;2053-2062.
58. Schratt G., Weinhold B., Lundberg A.S., Schuck S., Berger J., Schwarz H., et al. Serum response factor is required for immediate-early gene activation yet is dispensable for proliferation of embryonic stem cells. Mol Cell Biol. 21:2001;2933-2943.
59. Schratt G., Philippar U., Berger J., Schwarz H., Heidenreich O., Nordheim A. Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cells. J Cell Biol. 156:2002;737-750.
60. Escalante R., Vicente J.J., Moreno N., Sastre L. The MADS-box gene srfA is expressed in a complex pattern under the control of alternative promoters and is essential for different aspects of Dictyostelium development. Dev Biol. 235:2001;314-329.
61. Fraser A.G., Kamath R.S., Zipperlen P., Martinez-Campos M., Sohrmann M., Ahringer J. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature. 408:2000;325-330.
62. Guillemin K., Groppe J., Dücker K., Treisman R., Hafen E., Affolter M., et al. The pruned gene encodes the Drosophila serum response factor and regulates cytoplasmic outgrowth during terminal branching of the tracheal system. Development. 122:1996;1353-1362.
63. Montagne J., Groppe J., Guillemin K., Krasnow M.A., Gehring W.J., Affolter M. The Drosophila serum response factor gene is required for the formation of intervein tissue of the wing and is allelic to blistered. Development. 122:1996;2589-2597.
64. Vogel A.M., Gerster T. A zebrafish homolog of the serum response factor gene is highly expressed in differentiating embryonic myocytes. Mech Dev. 81:1999;217-221.
65. Zhu H., Roy A.L., Roeder R.G., Prywes R. Serum response factor affects preinitiation complex formation by TFIID in vitro. New Biologist. 3:1991;455-464.
66. Zhu H., Joliot V., Prywes R. Role of transcription factor TFIIF in serum response factor-activated transcription. J Biol Chem. 269:1994;3489-3497.
67. Joliot V., Demma M., Prywes R. Interaction with RAP74 subunit of TFIIF is required for transcriptional activation by serum response factor. Nature. 373:1995;632-635.
68. Mack C.P., Thompson M.M., Lawrenz-Smith S.C., Owens G.K. Smooth muscle α-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex. Circ Res. 86:2000;221-232.
69. Zilberman A., Dave V., Miano J.M., Olson E.N., Periasamy M. Evolutionarily conserved promoter region containing CArG-like elements is crucial for smooth muscle myosin heavy chain gene expression. Circ Res. 82:1998;566-575.
70. Manabe I., Owens G.K. The smooth muscle myosin heavy chain gene exhibits smooth muscle subtype-selective modular regulation in vivo. J Biol Chem. 276:2001;39076-39087.
71. Herring B.P., Smith A.F. Telokin expression in A10 smooth muscle cells requires serum response factor. Am J Physiol. 272:1997;C1394-1404.
72. Rensen S.S.M., Thijssen V.L.J.L., De Vries C.J., Doevendans P.A., Detera-Wadleigh S.D., Van Eys G.J.J.M. Expression of the smoothelin gene is mediated by alternative promoters. Cardiovasc Res. 55:2002;850-863.
73. Hirschi K.K., Lai L., Belaguli N.S., Dean D.A., Schwartz R.J., Zimmer W.E. Transforming growth factor-β induction of smooth muscle cell phenotype requires transcriptional and post-transcriptional control of serum response factor. J Biol Chem. 277:2002;6287-6295.
74. Joutel A., Andreux F., Gaulis S., Domenga V., Cecillion M., Battail N., et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest. 105:2000;597-605.
75. 1-associated α subunit expressed in smooth muscle cells. J Cell Sci. 108:1995;537-544.
76. Taylor J.M., Mack C.P., Nolan K., Regan C.P., Owens G.K., Parsons J.T. Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells. Mol Cell Biol. 21:2001;1565-1572.
77. Hsieh C.M., Yoshizumi M., Endege W.O., Kho C.J., Jain M.K. Kashiki S, et al. APEG-1, a novel gene preferentially expressed in aortic smooth muscle cells, is down-regulated by vascular injury. J Biol Chem. 271:1996;17354-17359.
78. Mack C.P., Owens G.K. Regulation of smooth muscle α-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions. Circ Res. 84:1999;852-861.
79. Nakano Y., Nishihara T., Sasayama S., Miwa T., Kamada S., Kakunaga T. Transcriptional regulatory elements in the 5' upstream and first intron regions of the human smooth muscle (aortic type) alpha-actin-encoding gene. Gene. 99:1991;285-289.
80. Obata H., Hayashi K., Nishida W., Momiyama T., Uchida A., Ochi T., et al. Smooth muscle cell phenotype-dependent transcriptional regulation of the α1 integrin gene. J Biol Chem. 272:1997;26643-26651.
81. Shin D., Garcia-Cardena G., Hayashi S- I., Gerety S., Asahara T., Stavrakis G., et al. Expression of EphrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev Biol. 230:2001;139-150.
82. Gale N.W., Baluk P., Pan L., Kwan M., Holash J., Dechiara T.M., et al. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth muscle cells. Dev Biol. 230:2001;151-160.
83. Li L., Liu Z.C., Mercer B., Overbeek P., Olson E.N. Evidence for serum response factor-mediated regulatory networks governing SM22α transcription in smooth, skeletal, and cardiac muscle cells. Dev Biol. 187:1997;311-321.
84. Kim S., Ip H.S., Lu M.M., Clendenin C., Parmacek M.S. A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages. Mol Cell Biol. 17:1997;2266-2278.
85. Chin M.T., Maemura K., Fukumoto S., Jain M.K., Layne M.D., Watanabe M., et al. Cardiovascular basic helix loop helix factor 1, a novel transcriptional repressor expressed preferentially in the developing and adult cardiovascular system. J Biol Chem. 275:2000;6381-6387.
86. Lilly B., Olson E.N., Beckerle M.C. Identification of a CArG box-dependent enhancer within the cysteine-rich protein 1 gene that directs expression in arterial but not venous or visceral smooth muscle cells. Dev Biol. 240:2001;531-547.
87. Wang D- Z., Chang P.S., Wang Z., Sutherland L., Richardson J.A., Small E., et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell. 105:2001;851-862.
88. Chen J., Kitchen C.M., Streb J.W., Miano J.M. Myocardin: a component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol. 34:2002;1345-1356.
89. Ellis P.D., Chen Q., Barker P.J., Metcalfe J.C., Kemp P.R. Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury. Arterioscler Thromb Vasc Biol. 20:2000;1912-1919.
90. Jiang Z., Wallner M., Meera P., Toro L. Human and rodent MaxiK channel β-subunit genes: cloning and characterization. Genomics. 55:1999;57-67.
91. Nakamura M., Nishida W., Mori S., Hiwada K., Hayashi K., Sobue K. Transcriptional activation of β-tropomyosin mediated by serum response factor and a novel Barx homologue, Barx1b, in smooth muscle cells. J Biol Chem. 276:2001;18313-18320.
92. Watanabe M., Layne M.D., Hsieh C.M., Maemura K., Gray S., Lee M.E., et al. Regulation of smooth muscle cell differentiation by AT-rich interaction domain transcription factors Mrf2α and Mrf2β Circ Res. 91:2002;382-389.
93. Meech R., Makarenkova H., Edelman D.B., Jones F.S. The homeodomain protein Barx2 promotes myogenic differentiation and is regulated by myogenic regulatory factors. J Biol Chem. 278:2003;8269-8278.
94. Andrés V., Fisher S., Wearsch P., Walsh K. Regulation of Gax homeobox gene transcription by a combination of positive factors including myocyte-specific enhancer factor 2. Mol Cell Biol. 15:1995;4272-4281.
95. Bashir M.M., Indik Z., Yeh H., Ornstein-Goldstein N., Rosenbloom J.C., Abrams W., et al. Characterization of the complete human elastin gene: delineation of unusual features in the 5' flanking region. J Biol Chem. 264:1989;8887-8891.
96. Katchman S.D., Hsu-Wong S., Ledo I., Wu M., Uitto J. Transforming growth factor-β up-regulates human elastin promoter activity in transgenic mice. Biochem Biophys Res Commun. 203:1994;485-490.
97. Mericskay M., Parlakian A., Porteu A., Dandré F., Bonnet J., Paulin D., et al. An overlapping CArG/Octamer element is required for regulation of desmin gene transcription in arterial smooth muscle cells. Dev Biol. 226:2000;192-208.
98. Gilgenkrantz H., Hugnot J- P., Lambert M., Chafey P., Kaplan J- C., Kahn A. Positive and negative regulatory DNA elements including a CCArGG box are involved in the cell type-specific expression of the human muscle dystrophin gene. J Biol Chem. 267:1992;10823-10830.
99. Moiseeva E.P., Belkin A.M., Spurr N.K., Koteliansky V.E., Critchley D.R. A novel dystrophin/utrophin-associated protein is an enzymatically inactive member of the phosphoglucomutase superfamily. Eur J Biochem. 235:1996;103-113.
100. Momiyama T., Hayashi K., Obata H., Chimori Y., Nishida T., Ito T., et al. Functional involvement of serum response factor in the transcriptional regulation of caldesmon gene. Biochem Biophys Res Comm. 242:1998;429-435.
101. Moiseeva E.P., Weller P.A., Zhidkova N.I., Corben E.B., Patel B., Jasinska I., et al. Organization of the human gene encoding the cytoskeletal protein vinculin and the sequence of the vinculin promoter. J Biol Chem. 268:1993;4318-4325.
102. Hungerford J.E., Hoeffler J.P., Bowers C.W., Dahm L.M., Falchetto R., Shabanowitz J., et al. Identification of a novel marker for primordial smooth muscle and its differential expression pattern in contractile vs noncontractile cells. J Cell Biol. 137:1997;925-937.
103. Layne M.D., Endege W.O., Jain M.K., Yet S.F., Hsieh C.M., Chin M.T., et al. Aortic carboxypeptidase-like protein, a novel protein with discoidin and carboxypeptidase-like domains, is up-regulated during vascular smooth muscle cell differentiation. J Biol Chem. 273:1998;15654-15660.
104. Herrera V.L.M., Ruiz-Opazo N. Regulation of α-tropomyosin and N5 genes by a shared enhancer: modular structure and hierarchical organization. J Biol Chem. 265:1990;9555-9562.
105. Smith A.F., Bigsby R.M., Word A., Herring B.P. A 310-bp minimal promoter mediates smooth muscle cell-specific expression of telokin. Am J Physiol. 274:1998;C1188-C1195. (Cell Physiol).
106. Hoggatt A.M., Simon G.M., Herring B.P. Cell-specific regulatory modules control expression of genes in vascular and visceral smooth muscle tissues. Circ Res. 91:2002;1151-1159.
107. Kimura S., Abe K., Suzuki M., Ogawa M., Yoshioka K., Kaname T., et al. A 900 bp genomic region from the mouse dystrophin promoter directs lacZ reporter expression only to the right heart of transgenic mice. Dev Growth Differ. 39:1997;257-265.
108. Ogawa M., Kaname T., Kimura S., Kawasaki I., Nomura K., Suzuki M., et al. The lacZ gene under the control of the 7 kb of human dystrophin muscle specific promoter is expressed in cardiac muscle but not in adult skeletal muscle in transgenic mice. Neuromuscul Disord. 11:2001;244-250.
109. Raguz S., Hobbs C., Yague E., Ioannou P.A., Walsh F.S., Antoniou M. Muscle-specific locus control region activity associated with the human desmin gene. Dev Biol. 201:1998;26-42.
110. Krämer J., Quensel C., Meding J., Cardosa M.C., Leonhardt H. Identification and characterization of novel smoothelin isoforms in vascular smooth muscle. J Vasc Res. 38:2001;120-132.
111. Li L., Miano J.M., Mercer B., Olson E.N. Expression of the SM22α promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol. 132:1996;849-859.
112. Moessler H., Mericskay M., Li Z., Nagl S., Paulin D., Small J.V. The SM 22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development. 122:1996;2415-2425.
113. Strobeck M., Kim S., Zhang J.C.L., Clendenin C., Du K.L., Parmacek M.S. Binding of serum response factor to CArG box sequences is necessary but not sufficient to restrict gene expression to arterial smooth muscle cells. J Biol Chem. 276:2001;16418-16424.
114. Chang P.S., Li L., Mcanally J., Olson E.N. Muscle specificity encoded by specific serum response factor-binding sites. J Biol Chem. 276:2001;17206-17212.
115. Madsen C.S., Hershey J.C., Hautmann M.B., White S.L., Owens G.K. Expression of the smooth muscle myosin heavy chain gene is regulated by a negative-acting GC-rich element located between two positive-acting serum response factor-binding elements. J Biol Chem. 272:1997;6332-6340.
116. Browning C.L., Culberson D.E., Aragon I.V., Fillmore R.A., Croissant J.D., Schwartz R.J., et al. The developmentally regulated expression of serum response factor plays a key role in the control of smooth muscle-specific genes. Dev Biol. 194:1998;18-37.
117. Shimizu R.T., Blank R.S., Jervis R., Lawrenz-Smith S.C., Owens G.K. The smooth muscle α-actin gene promoter is differentially regulated in smooth muscle versus non-smooth muscle cells. J Biol Chem. 270:1995;7631-7643.
118. Qian J., Kumar A., Szucsik J.C., Lessard J.L. Tissue and developmental specific expression of murine smooth muscle gamma-actin fusion genes in transgenic mice. Dev Dyn. 207:1996;135-144.
119. Miano J.M., Kitchen C.M., Chen J., Maltby K.M., Kelly L.A., Weiler H., et al. Expression of human smooth muscle calponin in transgenic mice revealed with a bacterial artificial chromosome. Am J Physiol Heart Circ Physiol. 282:2002;H1793-H1803.
120. Xu R., Ho Y.S., Ritchie R.P., Li L. Human SM22 alpha BAC encompasses regulatory sequences for expression in vascular and visceral smooth muscle at fetal and adult stages. Am J Physiol Heart Circ Physiol. 284:2003;H1398-H1407.
121. Madsen C.S., Regan C.P., Hungerford J.E., White S.L., Manabe I., Owens G.K. Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5'-flanking and first intronic DNA sequence. Circ Res. 82:1998;908-917.
122. Franz W.M., Mueller O.J., Fleischmann M., Babij P., Frey N., Mueller M., et al. The 2.3 kb smooth muscle myosin heavy chain promoter directs gene expression into the vascular system of transgenic mice and rabbits. Cardiovasc Res. 43:1999;1040-1048.
123. Sindermann J.R., Babij P., Klink J.C., Köbbert C., Plenz G., Ebbing J., et al. Smooth muscle-specific expression of SV40 large TAg induces SMC proliferation causing adaptive arterial remodeling. Am J Physiol Heart Circ Physiol. 283:2002;H2714-H2724.
124. Manabe I., Owens G.K. CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo. J Clin Invest. 107:2001;823-834.
125. Kawada N., Moriyama T., Ando A., Koyama T., Hori M., Miwa T., et al. Role of intron 1 in smooth muscle α-actin transcriptional regulation in activated mesangial cells in vivo. Kid Int. 55:1999;2338-2348.
126. Marigo V., Volpin D., Vitale G., Bressan G.M. Identification of a TGF-β responsive element in the human elastin promoter. Biochem Biophys Res Comm. 199:1994;1049-1056.
127. Hautmann M.B., Madsen C.S., Owens G.K. A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J Biol Chem. 272:1997;10948-10956.
128. Adam P.J., Regan C.P., Hautmann M.B., Owens G.K. Positive- and negative-acting Krüppel-like transcription factors bind a transforming growth factor β control element required for expression of the smooth muscle cell differentiation marker SM22α in vivo. J Biol Chem. 275:2000;37798-37806.
129. Chen S., Kulik M., Lechleider R.J. Smad proteins regulate transcriptional induction of the SM22α gene by TGF-β Nucl Acid Res. 31:2003;1302-1310.
130. Wada H., Hasegawa K., Morimoto T., Kakita T., Yanazume T., Abe M., et al. Calcineurin-GATA-6 pathway is involved in smooth muscle-specific transcription. J Cell Biol. 156:2002;983-991.
131. Ohkawa Y., Hayashi K., Sobue K. Calcineurin-mediated pathway involved in the differentiated phenotype of smooth muscle cells. Biochem Biophys Res Comm. 301:2003;78-83.
132. Wada H., Hasegawa K., Morimoto T., Kakita T., Yanazume T., Sasayama S. A p300 protein as a coactivator of GATA-6 in the transcription of the smooth muscle-myosin heavy chain gene. J Biol Chem. 275:2000;25330-25335.
133. Chen J.C.J., Ramachandran R., Goldhamer D.J. Essential and redundant functions of the MyoD distal regulatory region revealed by targeted mutagenesis. Dev Biol. 245:2002;213-223.
134. Yanagisawa H., Clouthier D.E., Richardson J.A., Charité J., Olson E.N. Targeted deletion of a branchial arch-specific enhancer reveals a role of dHAND in craniofacial development. Development. 130:2003;1069-1078.
135. Rivera V.M., Miranti C.K., Misra R.P., Ginty D.D., Chen R- H., Blenis J., et al. A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity. Mol Cell Biol. 13:1993;6260-6273.
136. Hautmann M.B., Thompson M.M., Swartz E.A., Olson E.N., Owens G.K. Angiotensin II-induced stimulation of smooth muscle α-actin expression by serum response factor and the homeodomain transcription factor MHox. Circ Res. 81:1997;600-610.
137. Hautmann M., Adam P.J., Owens G.K. Similarities and differences in smooth muscle α-actin induction by TGF-β in smooth muscle versus non-smooth muscle cells. Arterioscler Thromb Vasc Biol. 19:1999;2049-2058.
138. Kemp P.R., Metcalfe J.C. Four isoforms of serum response factor that increase or inhibit smooth muscle-specific promoter activity. Biochem J. 345:2000;445-451.
139. Yang Y., Beqaj S., Kemp P., Ariel I., Schuger L. Stretch-induced alternative splicing of serum response factor promotes bronchial myogenesis and is defective in lung hypoplasia. J Clin Invest. 106:2000;1321-1330.
140. Camoretti-Mercado B., Liu H- W., Halayko A.J., Forsythe S.M., Kyle J.W., Li B., et al. Physiological control of smooth muscle-specific gene expression through regulated nuclear translocation of serum response factor. J Biol Chem. 275:2000;30387-30393.
141. Beqaj S., Jakkaraju S., Mattingly R.R., Pan D., Schuger L. High RhoA activity maintains the undifferentiated mesenchymal cell phenotype, whereas RhoA down-regulation by laminin-2 induces smooth muscle myogenesis. J Cell Biol. 156:2002;893-903.
142. Qiu P., Li L. Histone acetylation and recruitment of serum responsive factor and CREB-binding protein onto SM22 promoter during SM22 gene expression. Circ Res. 90:2002;858-865.
143. Drewett V., Devitt A., Saxton J., Portman N., Greaney P., Cheong N., et al. Serum response factor cleavage by caspases 3 and 7 linked to apoptosis in human BJAB cells. J Biol Chem. 276:2001;33444-33451.
144. Kim S- W., Kim H- J., Jung D- J., Lee S- K., Kim Y- S., Kim J.H., et al. Retinoid-dependent antagonism of serum response factor transactivation mediated by transcriptional coactivator proteins. Oncogene. 20:2001;6638-6642.
145. Mack C.P., Somlyo A.V., Hautmann M.B., Somlyo A.P., Owens G.K. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem. 276:2001;341-347.
146. Lu J., Landerholm T.E., Wei J.S., Dong X- R., Wu S- P., Liu X., et al. Coronary smooth muscle differentiation from proepicardial cells requires RhoA-mediated actin reorganization and p160 Rho-kinase activity. Dev Biol. 240:2001;404-418.
147. Carson J.A., Fillmore R.A., Schwartz R.J., Zimmer W.E. The smooth muscle γ-actin gene promoter is a molecular target for the mouse bagpipe homologue, mNkx3-1, and serum response factor. J Biol Chem. 275:2000;39061-39072.
148. Nishida W., Nakamura M., Mori S., Takahashi M., Ohkawa Y., Tadokoro S., et al. A triad of serum response factor and the GATA and NK families governs the transcription of smooth and cardiac muscle genes. J Biol Chem. 277:2002;7308-7317.
149. Phiel C.J., Gabbeta V., Parsons L.M., Rothblat D., Harvey R.P., Mchugh K.M. Differential binding of an SRF/NK-2/MEF2 transcription factor complex in normal versus neoplastic smooth muscle tissues. J Biol Chem. 276:2001;34637-34650.
150. Wang D.Z., Li S., Hockemeyer D., Sutherland L., Wang Z., Schratt G., et al. Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc Natl Acad Sci USA. 99:2002;14855-14860.
151. Herring B.P., Kriegel A.M., Hoggatt A.M. Identification of Barx2B, a serum response factor-associated homeodomain protein. J Biol Chem. 276:2001;14482-14489.
152. Chin M.T., Pellacani A., Wang H., Lin S.S.J., Jain M.K., Perrella M.A., et al. Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y). J Biol Chem. 273:1998;9755-9760.
153. Spencer J.A., Baron M.H., Olson E.N. Cooperative transcriptional activation by serum response factor and the high mobility group protein SSRP1. J Biol Chem. 274:1999;15686-15693.
154. Hirschi K.K., Rohovsky S.A., D'Amore P.A.P.D.G.F. TGF-β, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol. 141:1998;805-814.
155. Itoh S., Katoh Y., Konishi H., Takaya N., Kimura T., Periasamy M., et al. Nitric oxide regulates smooth-muscle-specific myosin heavy chain gene expression at the transcriptional level-possible role of SRF and YY1 through CArG element. J Mol Cell Cardiol. 33:2001;95-107.
156. Walsh K., Schimmel P. Two nuclear factors compete for the skeletal muscle actin promoter. J Biol Chem. 262:1987;9429-9432.
157. Lee T.-.C., Shi Y., Schwartz R.J. Displacement of BrdUrd-induced YY1 by serum response factor activates skeletal α-actin transcription in embryonic myoblasts. Proc Natl Acad Sci, USA. 89:1992;9814-9818.
158. Ellis P.D., Martin K.M., Rickman C., Metcalfe J.C., Kemp P.R. Increased actin polymerization reduces the inhibition of serum response factor activity by Yin Yang 1. Biochem J. 364:2002;547-554.
159. Santiago F.S., Lowe H.C., Bobryshev Y.V., Khachigian L.M. Induction of the transcriptional repressor Yin Yang-1 by vascular cell injury: autocrine/paracrine role of endogenous fibroblast growth factor-2. J Biol Chem. 276:2001;41143-41149.
160. Chen F., Kook H., Milewski R., Gitler A.D., Lu M.M., Li J., et al. HOP is an unusual homoebox gene that modulates cardiac development. Cell. 110:2002;713-723.
161. Shin C.H., Liu Z- P., Passier R., Zhang C- L., Wang D- Z., Harris T.M., et al. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell. 110:2002;725-735.
162. International human genome sequencing consortium. Initial sequencing and analysis of the human genome. Nature. 409:2001;860-921.
163. Belaguli N.S., Zhou W., Trinh T- H.T., Majesky M.W., Schwartz R.J. Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets. Mol Cell Biol. 19:1999;4582-4591.
164. Cornforth M.N., Greulich-Bode K.M., Loucas B.D., Arsuaga J., Vázquez M., Sachs R.K., et al. Chromosomes are predominantly located randomly with respect to each other in interphase human cells. J Cell Biol. 159:2002;237-244.
165. Davis F.J., Gupta M., Pogwizd S.M., Bacha E., Jeevanandam V., Gupta M.P. Increased expression of alternatively spliced dominant negative isoform of SRF in human failing hearts. Am J Physiol Heart Circ Physiol. 282:2002;H1521-1533.
166. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature. 403:2000;41-45.
167. Manabe I., Owens G.K. Recruitment of serum response factor and hyperacetylation of histones at smooth muscle-specific regulatory regions during differentiation of a novel P19-derived in vitro smooth muscle differentiation system. Circ Res. 88:2001;1127-1134.
168. Hill C.S., Wynne J., Treisman R. The Rho family GTPases RhoA, Rac1, and cdc42Hs regulate transcriptional activation by SRF. Cell. 81:1995;1159-1170.
169. Sotiropoulos A., Gineitis D., Copeland J., Treisman R. Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell. 98:1999;159-169.
170. Gineitis D., Treisman R. Differential usage of signal transduction pathways defines two types of serum response factor target gene. J Biol Chem. 276:2001;24531-24539.
171. Copeland J.W., Treisman R. The diaphanous-related formin mDia1 controls serum response factor activity through its effects on actin polymerization. Mol Biol Cell. 13:2002;4088-4099.
172. Sartorelli V., Webster K.A., Kedes L. Muscle-specific expression of the cardiac α-actin gene requires MyoD1, CArG-box bindingfactor, and Sp1. Genes Dev. 4:1990;1811-1822.
173. Sepulveda J.L., Vlahopoulos S., Iyer D., Belaguli N.S., Schwartz R.J. Combinatorial expression of GATA4, Nkx2-5, and serum response factor directs early cardiac gene activity. J Biol Chem. 277:2002;25775-25782.
174. Mano T., Luo Z., Malendowicz S.L., Evans T., Walsh K. Reversal of GATA-6 downregulation promotes smooth muscle differentiation and inhibits intimal hyperplasia in balloon-injured rat carotid artery. Circ Res. 84:1999;647-654.
175. Aravind L., Koonin E.V. SAP-a putative DNA-binding motif involved in chromosomal organization. Trend Biochem Sci. 25:2000;112-114.
176. Du K., Ip H.S., Li J., Chen M., Dandre F., Yu W., et al. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol. 23:2003;2425-2437.
177. Yoshida T., Sinha S., Dandre F., Wamhoff B.R., Hoofnagle M.H., Kremer B.E., Wang D.Z., Olson E.N., Owens G.K. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res. 92:2003;856-864.
178. Chang D.F., Belaguli N.S., Iyer D., Roberts W.B., Wu S.-.P., Dong X.-.R., et al. Cysteine-rich LIM-only proteins, CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Develop Cell. 4:2003;107-118.
179. Yan H., Yuan W., Velculescu V.E., Vogelstein B., Kinzler K.W. Allelic variation in human gene expression. Science. 297:2002;1143.
180. Cowles C.R., Hirschhorn J.N., Altshuler D., Lander E.S. Detection of regulatory variation in mouse genes. Nat Genet. 32:2002;432-437.
181. Banerjee P., Bahlo M., Schwartz J.R., Loots G.G., Houston K.A., Dubchak I., et al. SNPs in putative regulatory regions identified by human mouse comparative sequencing and transcription factor binding site data. Mamm Genome. 13:2002;554-557.
182. Loots G.G., Ovcharenko I., Pachter L., Dubchak I., Rubin E.M. rVISTA for comparative sequence-based discovery of functional transcription factor binding sites. Genom Res. 12:2002;832-839.
183. Halfon M.S., Grad Y., Church G.M., Michelson A.M. Computation-based discovery of related transcriptional regulatory modules and motifs using an experimentally validated combinatorial model. Genome Res. 12:2002;1019-1028.
184. Venkatesh B., Si-Hoe S.L., Murphy D., Brenner S. Transgenic rats reveal functional conservation of regulatory controls between the Fugu isotocin and rat oxytocin genes. Proc Natl Acad Sci, USA. 94:1997;12462-12466.
185. Regan C.P., Adam P.J., Madsen C.S., Owens G.K. Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. J Clin Invest. 106:2000;1139-1147.